Imported diphyllobothriasis in Switzerland: molecular methods to define a clinical case of Diphyllobothrium infection as Diphyllobothrium dendriticum, August 2010.
Following a first clinical case of infection by Diphyllobothrium dendriticum in Switzerland in 2006, we report a second case in the country. The species was identified by molecular methods. In the Swiss, French and Italian subalpine regions, human diphyllobothriasis has seen a comeback since the late 1980's, and Diphyllobothrium latum is usually considered the causative agent of the disease. In addition, several locally acquired and imported clinical infections due to allochthonous Diphyllobothrium species have been documented in the last years. Due to the colonisation potential of these parasites and their probably underestimated presence in the human population, there is a need for discriminating them at the medical laboratory level. Because the morphological characters are very similar among the different taxa, a correct identification requires the use of molecular methods. Molecular identification would improve diagnosis and help monitor the distribution of Diphyllobothrium species in Europe.
Dianalabs, Geneva, Switzerland.
F
F
de Marval
B
B
Gottstein
M
M
Weber
B
B
Wicht
D000818:Animals; D002675:Child, Preschool; D004169:Diphyllobothriasis / Q000175:diagnosis* / Q000453:epidemiology / Q000469:parasitology; D004170:Diphyllobothrium / Q000145:classification / Q000235:genetics*; D005243:Feces / Q000469:parasitology; D006801:Humans; D008297:Male; D016133:Polymerase Chain Reaction; D011223:Praziquantel / Q000627:therapeutic use*; D019914:Taq Polymerase; D014195:Travel
D011223:Praziquantel; D019914:Taq Polymerase